Prior to the widespread adoption of lipidation, albumin binding, and fusion strategies, many peptides were dismissed as clinically impractical solely because of their dosing frequency
Finally, an analysis of some of the original trials for the use of semaglutide in weight management (STEP 1, 2, 3 and 5) found no significant increase in depressive symptoms or suicidal ideation/behavior
Lower incidence of deep vein thrombosis, pulmonary embolism, and pulmonary hypertension, likely due to effects on endothelial function and clotting
Even with insurance, many plans require prior authorization, step therapy through cheaper medications first, or simply do not cover weight loss indications at all
2018 Dec;108:952-962
Top tips for managing GLP-1 agonist side effects We recommend the following to help you manage the side effects listed above